Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Gerstoft

Showing results (271-280 of 306) with videos related to

Pageof 31
Sort By:
Infectious Diseases (London, England)|October 16, 2018
Limited anti-HIV neutralizing antibody breadth and potency before and after HIV superinfection in Danish men who have sex with menAndrew D Redd, Marie Helleberg, Matthew Sievers, et al.
AIDS (London, England)|December 6, 2022
Association between ten-eleven methylcytosine dioxygenase 2 genetic variation and viral load in people with HIVDaniel D Murray, Birgit Grund, Cameron R MacPherson, et al.
The Journal of Infectious Diseases|August 23, 2003
Randomized trial to evaluate indinavir/ritonavir versus saquinavir/ritonavir in human immunodeficiency virus type 1-infected patients: the MaxCmin1 TrialUlrik Bak Dragsted, Jan Gerstoft, Court Pedersen, et al.
Cell Reports|April 15, 2014
HIV-1 adaptation to antigen processing results in population-level immune evasion and affects subtype diversificationStefan Tenzer, Hayley Crawford, Phillip Pymm, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 19, 2023
Risk of Depression in People With Human Immunodeficiency Virus: A Nationwide Population-based Matched Cohort StudyCecilie V Vollmond, Malte M Tetens, Fie W Paulsen, et al.
The Lancet. HIV|November 2, 2015
Bone mineral density and inflammatory and bone biomarkers after darunavir-ritonavir combined with either raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults with HIV-1: a substudy of the NEAT001/ANRS143 randomised trialJose I Bernardino, Amanda Mocroft, Patrick W Mallon, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 31, 2023
Incidence of Childbirth, Pregnancy, Spontaneous Abortion, and Induced Abortion Among Women With Human Immunodeficiency Virus in a Nationwide Matched Cohort StudyFie W Paulsen, Malte M Tetens, Cecilie V Vollmond, et al.
AIDS (London, England)|November 26, 2024
Use of nonbarrier contraceptives among women with HIVFie W Paulsen, Malte M Tetens, Jan Gerstoft, et al.
Scientific Reports|May 2, 2018
Impact of HIV and Type 2 diabetes on Gut Microbiota Diversity, Tryptophan Catabolism and Endothelial DysfunctionHedda Hoel, Malene Hove-Skovsgaard, Johannes R Hov, et al.
Scandinavian Journal of Gastroenterology|May 4, 2018
Direct acting antiviral treatment of chronic hepatitis C in Denmark: factors associated with and barriers to treatment initiationChristina Sølund, Sofie Hallager, Martin S Pedersen, et al.
Pageof 31

Showing results (271-280 of 306) with videos related to

Sort By:
Pageof 31
Infectious Diseases (London, England)|October 16, 2018
Limited anti-HIV neutralizing antibody breadth and potency before and after HIV superinfection in Danish men who have sex with menAndrew D Redd, Marie Helleberg, Matthew Sievers, et al.
AIDS (London, England)|December 6, 2022
Association between ten-eleven methylcytosine dioxygenase 2 genetic variation and viral load in people with HIVDaniel D Murray, Birgit Grund, Cameron R MacPherson, et al.
The Journal of Infectious Diseases|August 23, 2003
Randomized trial to evaluate indinavir/ritonavir versus saquinavir/ritonavir in human immunodeficiency virus type 1-infected patients: the MaxCmin1 TrialUlrik Bak Dragsted, Jan Gerstoft, Court Pedersen, et al.
Cell Reports|April 15, 2014
HIV-1 adaptation to antigen processing results in population-level immune evasion and affects subtype diversificationStefan Tenzer, Hayley Crawford, Phillip Pymm, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 19, 2023
Risk of Depression in People With Human Immunodeficiency Virus: A Nationwide Population-based Matched Cohort StudyCecilie V Vollmond, Malte M Tetens, Fie W Paulsen, et al.
The Lancet. HIV|November 2, 2015
Bone mineral density and inflammatory and bone biomarkers after darunavir-ritonavir combined with either raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults with HIV-1: a substudy of the NEAT001/ANRS143 randomised trialJose I Bernardino, Amanda Mocroft, Patrick W Mallon, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 31, 2023
Incidence of Childbirth, Pregnancy, Spontaneous Abortion, and Induced Abortion Among Women With Human Immunodeficiency Virus in a Nationwide Matched Cohort StudyFie W Paulsen, Malte M Tetens, Cecilie V Vollmond, et al.
AIDS (London, England)|November 26, 2024
Use of nonbarrier contraceptives among women with HIVFie W Paulsen, Malte M Tetens, Jan Gerstoft, et al.
Scientific Reports|May 2, 2018
Impact of HIV and Type 2 diabetes on Gut Microbiota Diversity, Tryptophan Catabolism and Endothelial DysfunctionHedda Hoel, Malene Hove-Skovsgaard, Johannes R Hov, et al.
Scandinavian Journal of Gastroenterology|May 4, 2018
Direct acting antiviral treatment of chronic hepatitis C in Denmark: factors associated with and barriers to treatment initiationChristina Sølund, Sofie Hallager, Martin S Pedersen, et al.
Pageof 31